Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs TRMB✓SelectedUSD · TRMBGSK vs TRMB performance historyLatest closeAs of-1.34%11/18
Stock and ETF performance explorer

GSK vs TRMB

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+102.1%
TRMB return
+90.9%
Excess return
+11.3%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioTRMBExcessAlpha
1D-1.3%+0.6%-1.9%-1.4%
7D-3.1%-4.5%+1.4%-2.6%
30D-0.9%-10.0%+9.1%-0.1%
3M-4.2%-5.4%+1.2%-4.1%
6M-1.6%-2.0%+0.4%-2.2%
YTD+2.6%-31.2%+33.8%+6.7%
1Y+6.2%-28.5%+34.7%+9.8%
3Y+55.0%+24.5%+30.5%+45.7%
5Y+42.8%-38.6%+81.4%+47.1%
10Y+102.1%+96.1%+6.0%+70.7%
All+102.1%+90.9%+11.3%+70.7%

Cumulative growth

Daily Returns

Daily percentage return beside TRMB.

Daily Out/Under-Performance

Portfolio return minus TRMB return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × TRMB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded TRMB wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling